​Breast

• (102-15) Data Registry for Early Stage Breast Cancer: Prospective Data Collection and Analyses of Wide Local Excisions and Intraoperative Radiotherapy (Phase 4 research study, appropriate for patients with early stage breast cancer.)

• (112-16) Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery (Phase 3 clinical trial, appropriate for patients with early-stage breast cancer.)

• (125-18) The DCISionRT Registry (Research study, appropriate for patients with ductal carcinoma in situ (DCIS) of the breast.)

• (131-17) A Phase 1/2 Safety Study of Intratumorally Administered INT230-6 in Adult Subjects with Advanced Refractory Cancers (Phase 1 clinical trial, appropriate for patients with solid tumors.)

• (152-17) A Modular Phase I, Open-Label, Multicentre Study to Assess Ascending Doses of AZD6738 in Combination With Chemotherapy and/or Novel Anti Cancer Agents (Phase 1 clinical trial, appropriate for patients with advanced solid malignancies of the breast.)

• (167-17) Caris ctDNA Validation Project (Research study, appropriate for patients with all solid tumors.)

• (177-18) PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors (Phase 1 clinical trial, appropriate for patients with HER2-positive breast cancer.)

• (187-17) Trial of ZW25 in Patients With Advanced HER2-expressing Cancers (Phase 1 clinical trial, appropriate for patients with HER2-expressing cancers.)

• (211-17) Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)

• (214-17) A Phase 1/2 First-in-human Study of BMS-986258 Alone and in Combination with Nivolumab in Advanced Malignant Tumors (Phase 1/2 clinical trial, appropriate for patients with advanced malignant tumors.)

Certain clinical trials may not be listed on ClinicalTrials.gov. To learn more about these or other clinical trials, please call 949-764-5543 or contact us online.